
GLP-1 Therapies: Promising Weight Loss Faces Access and Side-Effect Hurdles
GLP-1 drugs, originally diabetes meds, are increasingly used for obesity and have helped some patients with weight loss and even relief from joint inflammation, but they carry gastrointestinal side effects and reports of anhedonia; cost and uneven private insurance coverage pose access challenges, prompting doctors to explore dosing adjustments and underscoring that long-term outcomes and broader disease impact require more study.











